We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (βNGM Bioβ) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...
SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...
--Enrollment ongoing for patients with microsatellite stability (MSS) colorectal cancer (CRC) in Phase1/2 trial of NGM707, a dual ILT2/ILT4 antagonist antibody product candidate, in combination...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | -0.02 | -1.28205128205 | 1.56 | 1.58 | 1.54 | 1312747 | 1.55089379 | CS |
12 | 0.05 | 3.35570469799 | 1.49 | 2.2 | 1.345 | 1114057 | 1.58492385 | CS |
26 | 0.69 | 81.1764705882 | 0.85 | 2.2 | 0.6002 | 1009942 | 1.333874 | CS |
52 | -2.55 | -62.3471882641 | 4.09 | 4.69 | 0.6002 | 676878 | 1.59546702 | CS |
156 | -25.61 | -94.3278084715 | 27.15 | 30.13 | 0.6002 | 517339 | 8.03407993 | CS |
260 | -13.95 | -90.0581020013 | 15.49 | 32.12 | 0.6002 | 397471 | 10.71253051 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions